23C6

N/A

Report date: 2022/11/29 17:21:52

Base Information

Drug Name23C6
Drug Alias Name23-C-6
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionCadherin-1 antagonistsCadherin-11 antagonists
TargetsCadherin-1Cadherin-11
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMassachusetts General Hospital
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A